Talquetamab plus Teclistamab in Relapsed or Refractory Multiple Myeloma - Yael C. Cohen; Hila Magen; Moshe Gatt; Michael Sebag; Kihyun Kim; Chang-Ki Min; Enrique M. Ocio; Sung-Soo Yoon; Michael P. Chu; Paula Rodriguez-Otero; Irit Avivi; Natalia A. Quijano Cardé; et al. (New England Journal of Medicine, 2025)